Freehold Royalties About To Put More Money In Your Pocket (FRU)

On 9/26/14, Freehold Royalties Ltd (TSX: FRU.TO) will trade ex-dividend, for its monthly dividend of $0.14, payable on 10/15/14. As a percentage of FRU's recent stock price of $22.90, this dividend works out to approximately 0.61%, so look for shares of Freehold Royalties Ltd to trade 0.61% lower — all else being equal — when FRU shares open for trading on 9/26/14.

Below is a dividend history chart for FRU, showing historical dividends prior to the most recent $0.14 declared by Freehold Royalties Ltd:

FRU+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from FRU is likely to continue, and whether the current estimated yield of 7.34% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of FRU shares, versus its 200 day moving average:

Freehold Royalties Ltd 200 Day Moving Average Chart

Looking at the chart above, FRU's low point in its 52 week range is $21.41 per share, with $28.15 as the 52 week high point — that compares with a last trade of $22.90.

According to the ETF Finder at ETF Channel, FRU makes up 1.08% of the SuperDividend ETF ( SDIV) which is trading up by about 0.1% on the day Wednesday.

In Wednesday trading, Freehold Royalties Ltd shares are currently off about 0.2% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says